Prior exposure to biologics was associated with a decline in survival, with significantly larger reductions observed for ...

The Food and Drug Administration has approved Zoryve (roflumilast) topical foam, 0.3% for plaque psoriasis of the scalp and ...

Certain biologic therapies, such as ustekinumab, significantly effect hematological and lipid parameters in patients with psoriasis.

For patients with psoriasis receiving biologic therapy, residual inflammation (RI), defined as increased inflammatory markers in blood, characterized by high-sensitivity C-reactive protein, despite ...

If you have psoriasis, you may feel like this autoimmune disease is plenty to cope with all on its own. But unfortunately there are a number of other health issues linked to the condition.